Stanley T. Crooke

2018

In 2018, Stanley T. Crooke earned a total compensation of $7.6M as Chairman, President, Chief Executive Officer at Ionis Pharmaceuticals, a 4% increase compared to previous year.

Compensation breakdown

Bonus$759,257
Option Awards$4,073,394
Salary$883,242
Stock Awards$1,870,630
Other$39,056
Total$7,625,579

Crooke received $4.1M in option awards, accounting for 53% of the total pay in 2018.

Crooke also received $759.3K in bonus, $883.2K in salary, $1.9M in stock awards and $39.1K in other compensation.

Rankings

In 2018, Stanley T. Crooke's compensation ranked 1,085th out of 14,244 executives tracked by ExecPay. In other words, Crooke earned more than 92.4% of executives.

ClassificationRankingPercentile
All
1,085
out of 14,244
92nd
Division
Manufacturing
364
out of 5,758
94th
Major group
Chemicals And Allied Products
114
out of 2,119
95th
Industry group
Drugs
87
out of 1,808
95th
Industry
Pharmaceutical Preparations
61
out of 1,382
96th

Pay ratio

Stanley T. Crooke's Pay$7,625,579
Median Employee's Pay$244,261
Pay Ratio

31

to 1

In 2018, the annual total compensation of Stanley T. Crooke was $7,625,579.

The annual total compensation of the median employee at Ionis Pharmaceuticals was $244,261.

The ratio of Stanley T. Crooke's pay to the pay of median employee was therefore 31 to one.

Source: SEC filing on April 26, 2019.

Crooke's colleagues

We found five more compensation records of executives who worked with Stanley T. Crooke at Ionis Pharmaceuticals in 2018.

2018

B Parshall

Ionis Pharmaceuticals

Chief Operating Officer

2018

Brett Monia

Ionis Pharmaceuticals

Chief Operating Officer

2018

Richard Geary

Ionis Pharmaceuticals

Senior Vice President, Development

2018

Patrick O'Neil

Ionis Pharmaceuticals

General Counsel

2018

Elizabeth Hougen

Ionis Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like